Advertisement
Screener

ONYX PHARMACEUTICALS INC Operating Income

ONYX PHARMACEUTICALS INC Operating Income

ONYX PHARMACEUTICALS INC reported Operating Income of -$47.53 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.

Discontinued › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2013-08-09

  • ONYX PHARMACEUTICALS INC operating income (loss) for the quarter ending 2013-06-30 was -$47.53M.
  • ONYX PHARMACEUTICALS INC operating income (loss) for the quarter ending 2013-03-31 was -$28.47M.
  • ONYX PHARMACEUTICALS INC operating income (loss) for the quarter ending 2012-12-31 was -$38.21M, a 117.24% decline year-over-year.
  • ONYX PHARMACEUTICALS INC operating income (loss) for the quarter ending 2012-09-30 was -$72.35M.
  • ONYX PHARMACEUTICALS INC operating income (loss) for fiscal 2012 was -$267.09M, a 371.69% decline from fiscal 2011.
  • ONYX PHARMACEUTICALS INC operating income (loss) for fiscal 2011 was $98.31M.
  • ONYX PHARMACEUTICALS INC operating income (loss) for fiscal 2010 was -$68.32M, a 437.83% decline from fiscal 2009.
  • ONYX PHARMACEUTICALS INC operating income (loss) for fiscal 2009 was $20.22M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 6 monthOperating Income (Loss) 9 monthOperating Income (Loss) 12 month
2013-06-30-$47.53M
10-Q · filed 2013-08-09
-$76.01M
10-Q · filed 2013-08-09
-$114.22M
derived: sum of 3 quarters · filed 2013-08-09
-$186.57M
derived: sum of 4 quarters · filed 2013-08-09
2013-03-31-$28.47M
10-Q · filed 2013-05-08
-$66.68M
derived: sum of 2 quarters · filed 2013-05-08
-$139.03M
derived: sum of 3 quarters · filed 2013-05-08
-$244.81M
derived: sum of 4 quarters · filed 2013-08-09
2012-12-31-$38.21M
10-K · filed 2013-02-28
-$110.56M
derived: sum of 2 quarters · filed 2013-02-28
-$216.34M
derived: sum of 3 quarters · filed 2013-08-09
-$267.09M
10-K · filed 2013-02-28
2012-09-30-$72.35M
10-K · filed 2013-02-28
-$178.13M
derived: sum of 2 quarters · filed 2013-08-09
-$228.88M
10-Q · filed 2012-11-02
-$7.24M
derived: sum of 4 quarters · filed 2013-08-09
2012-06-30-$105.77M
10-Q · filed 2013-08-09
-$156.52M
10-Q · filed 2013-08-09
$65.11M
derived: sum of 3 quarters · filed 2013-08-09
$32.90M
derived: sum of 4 quarters · filed 2013-08-09
2012-03-31-$50.75M
10-Q · filed 2013-05-08
$170.88M
derived: sum of 2 quarters · filed 2013-05-08
$138.68M
derived: sum of 3 quarters · filed 2013-05-08
$88.87M
derived: sum of 4 quarters · filed 2013-05-08
2011-12-31$221.63M
10-K · filed 2013-02-28
$189.43M
derived: sum of 2 quarters · filed 2013-02-28
$139.62M
derived: sum of 3 quarters · filed 2013-02-28
$98.31M
10-K · filed 2013-02-28
2011-09-30-$32.21M
10-K · filed 2013-02-28
-$82.02M
derived: sum of 2 quarters · filed 2013-02-28
-$123.33M
10-Q · filed 2012-11-02
-$136.40M
derived: sum of 4 quarters · filed 2013-02-28
2011-06-30-$49.81M
10-K · filed 2013-02-28
-$91.12M
10-Q · filed 2012-08-06
-$104.19M
derived: sum of 3 quarters · filed 2013-02-28
-$57.44M
derived: sum of 4 quarters · filed 2013-02-28
2011-03-31-$41.31M
10-K · filed 2013-02-28
-$54.38M
derived: sum of 2 quarters · filed 2013-02-28
-$7.63M
derived: sum of 3 quarters · filed 2013-02-28
-$100.80M
derived: sum of 4 quarters · filed 2013-02-28
2010-12-31-$13.07M
10-K · filed 2012-02-27
$33.68M
derived: sum of 2 quarters · filed 2012-02-27
-$59.48M
derived: sum of 3 quarters · filed 2012-02-27
-$68.32M
10-K · filed 2013-02-28
2010-09-30$46.75M
10-K · filed 2012-02-27
-$46.41M
derived: sum of 2 quarters · filed 2012-02-27
-$55.26M
10-Q · filed 2011-11-03
-$56.73M
derived: sum of 4 quarters · filed 2012-02-27
2010-06-30-$93.16M
10-K · filed 2012-02-27
-$102.00M
10-Q · filed 2011-08-09
-$103.48M
derived: sum of 3 quarters · filed 2012-02-27
-$93.41M
derived: sum of 4 quarters · filed 2012-02-27
2010-03-31-$8.84M
10-K · filed 2012-02-27
-$10.31M
derived: sum of 2 quarters · filed 2012-02-27
-$252.00K
derived: sum of 3 quarters · filed 2012-02-27
$8.44M
derived: sum of 4 quarters · filed 2012-02-27
2009-12-31-$1.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27
$8.59M
derived: sum of 2 quarters · filed 2012-02-27
$17.28M
derived: sum of 3 quarters · filed 2012-02-27
$20.22M
10-K · filed 2012-02-27
2009-09-30$10.06M
10-Q · filed 2010-11-03
$18.75M
derived: sum of 2 quarters · filed 2010-11-03
$21.70M
10-Q · filed 2010-11-03
2009-06-30$8.69M
10-Q · filed 2010-08-04
$11.63M
10-Q · filed 2010-08-04
2008-12-31-$10.40M
10-K · filed 2011-02-23